Buscar
Chemed Corp
CHEAñadir a la lista de seguimiento
532.250USD
-2.450-0.46%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
7.30BCap. mercado
28.99P/E TTM
Más Datos de Chemed Corp Compañía
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Información de Chemed Corp
Símbolo de cotizaciónCHE
Nombre de la empresaChemed Corp
Fecha de salida a bolsaMay 27, 1971
Director ejecutivoMcnamara (Kevin J)
Número de empleados15695
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 27
Dirección255 E. Fifth Street,
CiudadCINCINNATI
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal45202
Teléfono15137626690
Sitio Webhttps://www.chemed.com/
Símbolo de cotizaciónCHE
Fecha de salida a bolsaMay 27, 1971
Director ejecutivoMcnamara (Kevin J)
Ejecutivos de Chemed Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas Charles Hutton, J.D.
Mr. Thomas Charles Hutton, J.D.
Director
Director
78.54K
+0.03%
Mr. Spencer S. Lee
Mr. Spencer S. Lee
Executive Vice President
Executive Vice President
14.91K
+2.31%
Dr. Andrea R. Lindell
Dr. Andrea R. Lindell
Independent Director
Independent Director
4.58K
-29.42%
Mr. Patrick P. Grace
Mr. Patrick P. Grace
Independent Director
Independent Director
3.72K
+8.76%
Mr. Christopher J. Heaney
Mr. Christopher J. Heaney
Independent Director
Independent Director
2.77K
+13.91%
Mr. Brian C. Judkins
Mr. Brian C. Judkins
Vice President, Chief Legal Officer, Secretary
Vice President, Chief Legal Officer, Secretary
2.44K
+10.22%
Mr. Ron DeLyons
Mr. Ron DeLyons
Independent Director
Independent Director
2.05K
+18.81%
Ms. Eileen P. Mccarthy
Ms. Eileen P. Mccarthy
Independent Director
Independent Director
1.24K
+31.10%
Mr. Kevin J. Mcnamara
Mr. Kevin J. Mcnamara
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. George J. Walsh, III
Mr. George J. Walsh, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thomas Charles Hutton, J.D.
Mr. Thomas Charles Hutton, J.D.
Director
Director
78.54K
+0.03%
Mr. Spencer S. Lee
Mr. Spencer S. Lee
Executive Vice President
Executive Vice President
14.91K
+2.31%
Dr. Andrea R. Lindell
Dr. Andrea R. Lindell
Independent Director
Independent Director
4.58K
-29.42%
Mr. Patrick P. Grace
Mr. Patrick P. Grace
Independent Director
Independent Director
3.72K
+8.76%
Mr. Christopher J. Heaney
Mr. Christopher J. Heaney
Independent Director
Independent Director
2.77K
+13.91%
Mr. Brian C. Judkins
Mr. Brian C. Judkins
Vice President, Chief Legal Officer, Secretary
Vice President, Chief Legal Officer, Secretary
2.44K
+10.22%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Chemed Corp?
Los cinco principales accionistas de Chemed Corp son: Mr. Thomas Charles Hutton, J.D.
¿Cuántas instituciones poseen acciones de Chemed Corp (CHE)?
A fecha de 2026Q1, 1092 instituciones poseen acciones de Chemed Corp, con un valor de mercado combinado de aproximadamente 13.97M, lo que representa el 105.26% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1981324.00.
¿Cuál es la mayor fuente de ganancias de Chemed Corp?
El 2026Q1, el segmento empresarial Short-term core generó la ganancia más alta para Chemed Corp, ascendiendo a 653.69M y representando el 25.84% de la ganancia total.